WO2021115047A1 - Microfluidic chip and whole blood separation method based on microfluidic chip - Google Patents

Microfluidic chip and whole blood separation method based on microfluidic chip Download PDF

Info

Publication number
WO2021115047A1
WO2021115047A1 PCT/CN2020/129487 CN2020129487W WO2021115047A1 WO 2021115047 A1 WO2021115047 A1 WO 2021115047A1 CN 2020129487 W CN2020129487 W CN 2020129487W WO 2021115047 A1 WO2021115047 A1 WO 2021115047A1
Authority
WO
WIPO (PCT)
Prior art keywords
plasma
microchannel
whole blood
microfluidic chip
blood
Prior art date
Application number
PCT/CN2020/129487
Other languages
French (fr)
Chinese (zh)
Inventor
陈思卉
陈希
杨慧
张翊
Original Assignee
深圳先进技术研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳先进技术研究院 filed Critical 深圳先进技术研究院
Publication of WO2021115047A1 publication Critical patent/WO2021115047A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502753Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/02Adapting objects or devices to another
    • B01L2200/026Fluid interfacing between devices or objects, e.g. connectors, inlet details
    • B01L2200/027Fluid interfacing between devices or objects, e.g. connectors, inlet details for microfluidic devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0631Purification arrangements, e.g. solid phase extraction [SPE]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/10Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0627Sensor or part of a sensor is integrated
    • B01L2300/0636Integrated biosensor, microarrays
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0829Multi-well plates; Microtitration plates
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0832Geometry, shape and general structure cylindrical, tube shaped
    • B01L2300/0838Capillaries

Definitions

  • the invention relates to the technical field of microfluidic technology, in particular to a microfluidic chip and a whole blood separation method based on the microfluidic chip.
  • blood contains a large proportion of disease markers in the human body. It is suitable for various tests such as immunodiagnosis, clinical biochemistry, and molecular diagnosis. It is currently the most commonly used sample object. Most of the tests performed on blood require the removal of blood cells from the blood for plasma or serum extraction during the sample pretreatment stage, or the need to enrich the cells in the blood for the next step of the relevant test. Different from traditional methods of whole blood separation such as centrifugation, filtration, and salting out, in the emerging field of in vitro diagnostics such as microfluidic technology and lab-on-a-chip, corresponding new miniaturized, highly integrated whole blood separation methods are required.
  • the current whole blood separation methods based on microfluidic technology can be divided into active and passive types according to whether external physical fields provide power or not. Active methods are not easy to integrate with other microfluidic functional devices because they involve complex control structures such as magnetism, electricity, and ultrasound.
  • the passive method mainly relies on fluid dynamics and microchannel geometry to achieve different behavioral control of blood.
  • the preparation process is relatively simple and easy to integrate. It shows advantages in the development of miniaturized point-of-care instruments.
  • passive microfluidic whole blood separation methods can be divided into three types: filtration, sedimentation, and directional cell migration. Different from the other two methods, the directional cell migration method achieves effective plasma extraction by directional control of the blood cell trajectory, which has advantages in the development of easy-to-manipulate high-purity whole blood separation devices.
  • the directional cell migration method is mainly used for the separation of whole blood in the following two realization schemes: 1. Deterministic lateral displacement method, the blood passes through a series of regular and orderly microstructures in the laminar flow process, and the cells will be of different sizes according to their own Deterministic lateral displacement occurs, thereby realizing the separation of plasma and blood cells; 2.
  • the hydrodynamic method uses the inertial force, viscous force, Dean vortex and other methods of the vertical or curved tube wall on the cell to achieve the orientation of the cell Migrate laterally to achieve the purpose of separation from plasma.
  • the current whole blood separation based on the above two methods requires a negative pressure pump or a fluid pump to provide power control to the blood, which is not easy for the microscopic separation of the overall separation device. miniaturization.
  • the present invention provides a microfluidic chip including a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array.
  • the whole blood is composed of the whole blood microchannel
  • the pores between the microcolumn arrays filter the blood cells with a larger size, and at the same time provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
  • the first micropillar array is spirally distributed.
  • the micropillars of the first micropillar array are cylindrical.
  • the diameter of the cylinder is 10-1000 microns, and the distance between adjacent cylinders is 0.5-2.5 microns.
  • a capillary pump structure is provided at the bottom of the whole blood microchannel and the plasma microchannel.
  • the capillary pump structure includes a second micropillar array structure.
  • the second micropillar array structure is arranged regularly.
  • the microfluidic chip has a single-layer or multi-layer structure, and the microchannel depth of the whole blood microchannel and the plasma microchannel is 10-2000 micrometers and the width is 10-5000 micrometers.
  • the present invention also provides a whole blood separation method of the microfluidic chip, which includes the following steps:
  • the movement of the blood to be separated spreads to the nearest micro-column of the first micro-column and stagnates at the gap between the micro-columns.
  • the blood to be separated is driven by the capillary force along the whole blood micro-channel, and at the same time in the process After passing through the micro-column gap in turn and stagnating, the pores between the micro-column arrays filter larger blood cells while providing capillary force to separate the plasma; the separated plasma will pass through the micro-column gap through the starting point and travel along the plasma micro-columns.
  • the channel is self-driving forward and triggers the micro-column gap flowing through one by one, continuously filtering out plasma from the whole blood;
  • the microfluidic chip provided by the present invention includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array.
  • the microchannel When whole blood enters through the whole blood microchannel, the microchannel The pores between the column arrays filter larger blood cells and provide capillary force to separate the plasma.
  • the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
  • the microfluidic chip provided by the present invention utilizes tiny pores. While filtering blood cells, it provides sufficient capillary force to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of stagnant separation of whole blood caused by clogging of blood cells, thereby improving The efficiency of whole blood separation.
  • FIG. 1 is a schematic structural diagram of a microfluidic chip provided by an embodiment of the present invention
  • Figure 2 is a schematic structural diagram of a capillary pump structure provided by an embodiment of the present invention.
  • Fig. 3 is a side view of a microfluidic chip provided by an embodiment of the present invention.
  • Fig. 4 is a process principle diagram of a microfluidic chip provided by an embodiment of the present invention.
  • FIG. 1 is a schematic structural diagram of a microfluidic chip provided by Embodiment 1 of the present invention, including: a first micropillar array 110 and a whole blood microchannel 120 and a plasma microchannel separated by the first micropillar array 110 130.
  • the first micropillar array 110 is spirally distributed. It can be understood that the micropillar array 110 may be distributed in an inner spiral or an outer spiral, and the orientation may be distributed from the outside to the inside or from the inside to the outside.
  • the distribution shape of the first micro-pillar array 110 is not limited to a spiral shape, and may be any unclosed revolving shape.
  • the micropillars of the first micropillar array 110 are cylindrical.
  • the diameter of the cylinder is 10-1000 microns, and the distance between adjacent cylinders is 0.5-2.5 microns. It can be understood that the cylindrical shape should correspond to the diameter of the inner recess of the red blood cell in the filtered blood with a smaller size.
  • micro-pillars are not limited to cylindrical shapes, but can also have various shapes such as squares and diamonds.
  • the size and adjacent spacing can be designed in different sizes under the condition of ensuring the feature size, so that the chip can handle different samples in different samples.
  • Cells of different sizes such as white blood cells with a diameter of 6-20 microns, platelets with a thickness of 0.5-1.5 microns, etc.
  • the pores between the micropillar arrays filter the blood cells with a larger size, and at the same time provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel , In order to achieve the separation of blood cells and plasma.
  • the bottoms of the whole blood microchannel 120 and the plasma microchannel 130 are both provided with a capillary pump structure 140, and the capillary pump structure 140 can collect and measure blood and plasma.
  • the capillary pump structure 140 includes a second micropillar array structure 141, and the second micropillar array structure 141 is arranged in an orderly and regular manner.
  • the shape, size, and size of the micro-pillars of the second micro-pillar array structure 141 can be designed with various parameters under the condition of ensuring the characteristic size.
  • the capillary pump structure 141 includes, but is not limited to, structures such as a Christmas tree shape, a serpentine channel shape, and the like.
  • FIG. 3 is a side view of a microfluidic chip provided by an embodiment of the present invention.
  • the microfluidic chip has a single-layer structure, that is, the channel depth of the whole blood microchannel 120 and the plasma microchannel 130 is equal to the depth of the first micropillar array 110.
  • the channel depth of the whole blood microchannel 120 and the plasma microchannel 130 is 10 to 2000 microns, and the width is 10 to 5000 microns.
  • the capillary force of blood in the microchannel will increase as the channel size decreases, with a higher flow rate, so that the microfluidic chip will achieve higher separation efficiency of whole blood; while the microfluidic control
  • the overall flux of the chip decreases as the channel size decreases. Therefore, the width and depth of the microchannel can be designed with different sizes according to the different focus requirements of different occasions, so that the final chip can achieve different application requirements.
  • the microfluidic chip provided by the above-mentioned embodiments of the present invention uses tiny pores to filter blood cells, while providing sufficient capillary force to the blood to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of blood cells.
  • the microfluidic chip provided by the present invention may be a material that can be manufactured by a micro-nano processing method, such as silicon-based materials such as monocrystalline silicon, silicon oxide, and silicon nitride, and specifically may also be glass materials such as quartz. , Or can be polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA) and other polymer materials.
  • a micro-nano processing method such as silicon-based materials such as monocrystalline silicon, silicon oxide, and silicon nitride, and specifically may also be glass materials such as quartz.
  • PDMS polydimethylsiloxane
  • PMMA polymethyl methacrylate
  • preparation methods include, but are not limited to, laser etching, 3D printing, photolithography, plasma etching and other micro-nano processing methods.
  • FIG. 4 is a process schematic diagram of a microfluidic chip provided by an embodiment of the present invention. The specific steps are as follows:
  • a layer of photoresist is suspended on the substrate, a corresponding microchannel mask is used to form a microchannel etching window through a photolithography process, and the anode film sacrificial layer is removed by an etching process.
  • the substrate is glass or silicon. It can be understood that the substrate includes, but is not limited to, glass materials such as quartz and silicon-based materials such as silicon oxide and silicon nitride.
  • the positive film sacrificial layer includes but is not limited to photoresist (including positive photoresist, negative photoresist and other photoresists), silicon oxide, silicon nitride, silicon carbide, or chromium, Metal materials such as aluminum.
  • microfluidic chip preparation process is not limited to the photoresist plasma etching method in the embodiment, and the microfluidic channel can be etched on glass or PMMA material by laser etching, and the microfluidic channel can be etched by photolithography.
  • the method is to prepare a micropillar array on a glass or silicon substrate, and then bond the two; or use a laser direct writing method to form patterns such as fluid channels on the surface of glass or organic materials.
  • etching includes but is not limited to plasma etching, deep silicon etching, and wet etching.
  • the removal process includes, but is not limited to, cleaning with concentrated sulfuric acid and hydrogen peroxide, and cleaning with other organic solvents. Craft.
  • S3 Perform surface chemical treatment on the microfluidic chip with a microchannel structure to realize the hydrophilic treatment of the surface of the microfluidic chip and improve the stability and uniformity of the physical and chemical properties of the chip surface.
  • the surface chemical treatment method for the microfluidic chip with the microchannel structure is not limited to chemical methods such as immersion, fumigation, spraying, etc., and electrochemical, thermal processing, vapor deposition and other methods can also be used.
  • the chemical treatment reagents used include, but are not limited to, polyethylene glycol (PEG) and 3-aminopropyl triethoxysilane ((3-aminopropyl) triethoxysilane, APTES), etc.
  • the treatment method used Including but not limited to fumigation, soaking, spraying, etc.
  • the following functions of the microfluidic chip can be achieved through surface chemical treatment: (1) Hydrophilization, which is beneficial to improve the capillary force driving ability of the whole blood sample on the surface; (2) Improve the uniformity and stability of the physical and chemical properties of the chip surface It can prevent the substrate from non-specific adsorption of cells and proteins in the blood, so that the whole blood sample is not prone to adhesion and stagnation when passing through.
  • the microfluidic chip prepared by the above steps includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array.
  • the pores between the microcolumn arrays filter the blood cells of larger size, and provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
  • the microfluidic chip provided by the above-mentioned embodiments of the present invention uses tiny pores to filter blood cells, while providing sufficient capillary force to the blood to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of blood cells.
  • the present invention also provides a whole blood separation method based on the microfluidic chip, which includes the following steps:
  • Step S110 the movement of the blood to be separated spreads to the nearest micro-pillar of the first micro-pillar, and stops at the gap between the micro-pillars, and the blood to be separated is self-driving along the whole blood microchannel under the action of capillary force, At the same time, the process passes through the subsequent micro-column gaps and stagnates.
  • the pores between the micro-column arrays filter larger blood cells and provide capillary force to separate the plasma; the separated plasma will pass through the micro-column gap through the starting point and travel along the path.
  • the plasma microchannel is self-driving forward and triggers the microcolumn gaps flowing through one by one to continuously filter the plasma from the whole blood.
  • the blood sample to be separated is added to the injection port of the microfluidic chip (A in Figure 3 is the injection port), and the blood to be separated has the injection port movement and spreads to the nearest first microcolumn ⁇ At the micro-column.
  • the inlet of the microfluidic chip is not limited to one sample inlet, and can be designed as multiple inlets.
  • Each inlet can be connected to a single or multiple first micropillar arrays, and each first micropillar array can also be Access single or multiple entrances.
  • Step S110 blood and plasma enter the capillary pump structure at the bottom ends of the whole blood microchannel and the plasma microchannel respectively, and the capillary pump structure collects and measures blood and plasma.
  • the microfluidic chip provided by the present invention includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array.
  • the microchannel When whole blood enters through the whole blood microchannel, the microchannel The pores between the column arrays filter larger blood cells and provide capillary force to separate the plasma.
  • the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
  • the microfluidic chip provided by the present invention utilizes tiny pores. While filtering blood cells, it provides sufficient capillary force to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of stagnant separation of whole blood caused by clogging of blood cells, thereby improving The efficiency of whole blood separation.
  • microfluidic chip provided by the present invention adopts a capillary force self-driving manner to realize whole blood separation, does not require an external power control device, and has more potential for the development of integration and miniaturization.
  • the microfluidic chip provided by the present invention is not limited to whole blood/plasma separation, but can also be used to separate and enrich different levels of biological objects in a solution system, such as circulating tumor cells at the cell level, such as extracellular vesicles at the subcellular level. Bubbles, liposomes, etc.
  • the positive electrode material of the microfluidic chip of the present invention can also have various transformations and modifications, and is not limited to the specific structure of the above-mentioned embodiment.
  • the protection scope of the present invention should include those alterations or substitutions and modifications that are obvious to those of ordinary skill in the art.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention provides a microfluidic chip, comprising a first micropillar array, and a whole blood microchannel and a plasma microchannel, which are separated by the first micropillar array. When whole blood enters the whole blood microchannel, the pores between the micropillar arrays filter the larger blood cells, and also provide a capillary force to separate the plasma, and the separated plasma enters the plasma microchannel, realizing the separation of blood cells and plasma. The microfluidic chip provided by the present invention filters the blood cells by means of the tiny pores and also provides a sufficient capillary force for blood so as to achieve whole blood separation without control from an external power; in addition, the continuous pore structure can solve the problem of the stagnation of whole blood separation caused by the clogging of blood cells, thereby improving the efficiency of whole blood separation.

Description

一种微流控芯片及基于微流控芯片的全血分离方法Microfluidic chip and whole blood separation method based on microfluidic chip 技术领域Technical field
本发明涉及微流控技术技术领域,特别涉及一种微流控芯片及基于微流控芯片的全血分离方法。The invention relates to the technical field of microfluidic technology, in particular to a microfluidic chip and a whole blood separation method based on the microfluidic chip.
背景技术Background technique
血液作为临床诊断中最普及的样本,包含了人体中极大比例的疾病标志物,适用于如免疫诊断、临床生化、分子诊断等多种检测,是目前最为常用的样本对象。大部分针对血液进行的检测,需要在样品预处理阶段,从血液中去除血细胞进行血浆或血清的提取,或需要富集血液中的细胞,以进行相关的下一步检测。与传统的离心、过滤和盐析等全血分离的方法不同,在微流控技术、芯片实验室等新兴的体外诊断领域,需要相应的新型微型化,高集成度的全血分离方法。As the most popular sample in clinical diagnosis, blood contains a large proportion of disease markers in the human body. It is suitable for various tests such as immunodiagnosis, clinical biochemistry, and molecular diagnosis. It is currently the most commonly used sample object. Most of the tests performed on blood require the removal of blood cells from the blood for plasma or serum extraction during the sample pretreatment stage, or the need to enrich the cells in the blood for the next step of the relevant test. Different from traditional methods of whole blood separation such as centrifugation, filtration, and salting out, in the emerging field of in vitro diagnostics such as microfluidic technology and lab-on-a-chip, corresponding new miniaturized, highly integrated whole blood separation methods are required.
目前基于微流控技术的全血分离方法可根据有无外源物理场提供动力而分为主动与被动式两类。主动式方法由于涉及磁、电、超声波等复杂控制结构,不易与其他微流控功能器件集成。被动式方法主要依靠流体动力学与微通道几何结构实现血液不同的行为控制,制备工艺相对简单,易于集成,在开发微小型化的床旁检测(Point-of-care)仪器上显现优势。根据分离原理的不同,被动式微流控全血分离方法可分为过滤、沉降和细胞定向迁移三种。与另外两种方法不同,细胞定向迁移法通过对血细胞运行轨迹进行定向操控以实现有效的血浆提取,在开发易操控的高纯度全血分离器件领域具有优势。The current whole blood separation methods based on microfluidic technology can be divided into active and passive types according to whether external physical fields provide power or not. Active methods are not easy to integrate with other microfluidic functional devices because they involve complex control structures such as magnetism, electricity, and ultrasound. The passive method mainly relies on fluid dynamics and microchannel geometry to achieve different behavioral control of blood. The preparation process is relatively simple and easy to integrate. It shows advantages in the development of miniaturized point-of-care instruments. According to different separation principles, passive microfluidic whole blood separation methods can be divided into three types: filtration, sedimentation, and directional cell migration. Different from the other two methods, the directional cell migration method achieves effective plasma extraction by directional control of the blood cell trajectory, which has advantages in the development of easy-to-manipulate high-purity whole blood separation devices.
目前细胞定向迁移法用于全血分离主要有以下两种实现方案:1、确定性侧向位移法,血液在层流过程中通过一系列规则有序的微结构,细胞会根据自身不同的尺寸发生确定性的侧向位移,由此实现血浆和血细胞的分离;2、流体动力法,利用竖直或弯曲管壁对细胞产生的惯性力、粘滞力、迪恩涡等方式实现细胞的定向侧向迁移,达到与血浆分离的目的。At present, the directional cell migration method is mainly used for the separation of whole blood in the following two realization schemes: 1. Deterministic lateral displacement method, the blood passes through a series of regular and orderly microstructures in the laminar flow process, and the cells will be of different sizes according to their own Deterministic lateral displacement occurs, thereby realizing the separation of plasma and blood cells; 2. The hydrodynamic method uses the inertial force, viscous force, Dean vortex and other methods of the vertical or curved tube wall on the cell to achieve the orientation of the cell Migrate laterally to achieve the purpose of separation from plasma.
由于血液本身粘稠度高,血浆分离后会进一步增大,所以目前基于上述两种方法实现的全血分离均需要通过负压泵或流体泵给血液提供动力控制,不易于整体分离装置的微小型化。Due to the high viscosity of the blood itself, the plasma will further increase after separation. Therefore, the current whole blood separation based on the above two methods requires a negative pressure pump or a fluid pump to provide power control to the blood, which is not easy for the microscopic separation of the overall separation device. miniaturization.
技术问题technical problem
有鉴如此,有必要针对现有技术存在的缺陷,提供一种全血分离效率高的微流控芯片及基于所述的微流控芯片的全血分离方法。In view of this, it is necessary to provide a microfluidic chip with high whole blood separation efficiency and a whole blood separation method based on the microfluidic chip in view of the defects of the prior art.
技术解决方案Technical solutions
为实现上述目的,本发明采用下述技术方案:In order to achieve the above objectives, the present invention adopts the following technical solutions:
一方面,本发明提供了一种微流控芯片,包括第一微柱阵列以及由所述第一微柱阵列分隔的全血微通道和血浆微通道,当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离。In one aspect, the present invention provides a microfluidic chip including a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array. When the whole blood is composed of the whole blood microchannel When entering, the pores between the microcolumn arrays filter the blood cells with a larger size, and at the same time provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
在一些较佳的实施例中,所述第一微柱阵列呈螺旋分布。In some preferred embodiments, the first micropillar array is spirally distributed.
在一些较佳的实施例中,所述第一微柱阵列的微柱呈圆柱状。In some preferred embodiments, the micropillars of the first micropillar array are cylindrical.
在一些较佳的实施例中,所述圆柱状的直径为10~1000微米,相邻圆柱间距为0.5~2.5微米。In some preferred embodiments, the diameter of the cylinder is 10-1000 microns, and the distance between adjacent cylinders is 0.5-2.5 microns.
在一些较佳的实施例中,所述全血微通道和血浆微通道的底部均设置毛细泵结构。In some preferred embodiments, a capillary pump structure is provided at the bottom of the whole blood microchannel and the plasma microchannel.
在一些较佳的实施例中,所述毛细泵结构包括第二微柱阵列结构。In some preferred embodiments, the capillary pump structure includes a second micropillar array structure.
在一些较佳的实施例中,所述第二微柱阵列结构呈规则排布。In some preferred embodiments, the second micropillar array structure is arranged regularly.
在一些较佳的实施例中,所述微流控芯片为单层或者多层结构,所述全血微通道和血浆微通道的微通道深度为10~2000微米,宽度为10~5000微米。In some preferred embodiments, the microfluidic chip has a single-layer or multi-layer structure, and the microchannel depth of the whole blood microchannel and the plasma microchannel is 10-2000 micrometers and the width is 10-5000 micrometers.
另外,本发明还提供了一种所述的微流控芯片的全血分离方法,包括下述步骤:In addition, the present invention also provides a whole blood separation method of the microfluidic chip, which includes the following steps:
待分离血液运动扩散至最近的所述第一微柱的微柱处,并在所述微柱间隙处停滞,待分离血液在毛细力作用下沿所述全血微通道自驱动,同时过程中依次经过后续微柱间隙并停滞,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来;分离的血浆将经起始点通过微柱间隙并沿所述血浆微通道向前自驱动,并逐个触发流经的微柱间隙,持续不断地从全血中过滤出血浆;The movement of the blood to be separated spreads to the nearest micro-column of the first micro-column and stagnates at the gap between the micro-columns. The blood to be separated is driven by the capillary force along the whole blood micro-channel, and at the same time in the process After passing through the micro-column gap in turn and stagnating, the pores between the micro-column arrays filter larger blood cells while providing capillary force to separate the plasma; the separated plasma will pass through the micro-column gap through the starting point and travel along the plasma micro-columns. The channel is self-driving forward and triggers the micro-column gap flowing through one by one, continuously filtering out plasma from the whole blood;
血液及血浆在所述全血微通道和所述血浆微通道的底端分别进入所述毛细泵结构,所述毛细泵结构收集、量取血液和血浆。Blood and plasma enter the capillary pump structure at the bottom ends of the whole blood microchannel and the plasma microchannel respectively, and the capillary pump structure collects and measures blood and plasma.
有益效果Beneficial effect
本发明采用上述技术方案的优点是:The advantages of the present invention using the above technical solution are:
本发明提供的微流控芯片,包括第一微柱阵列以及由所述第一微柱阵列分隔的全血微通道和血浆微通道,当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离,本发明提供的微流控芯片利用微小孔隙对血细胞进行过滤的同时,给血液提供足够的毛细力实现无外源动力控制的全血分离;另外,通过连续的孔隙结构可以解决因血细胞堵塞而带来的全血分离停滞的问题,从而提高全血分离的效率。The microfluidic chip provided by the present invention includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array. When whole blood enters through the whole blood microchannel, the microchannel The pores between the column arrays filter larger blood cells and provide capillary force to separate the plasma. The separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma. The microfluidic chip provided by the present invention utilizes tiny pores. While filtering blood cells, it provides sufficient capillary force to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of stagnant separation of whole blood caused by clogging of blood cells, thereby improving The efficiency of whole blood separation.
附图说明Description of the drawings
图1为本发明实施例提供的微流控芯片的结构示意图;FIG. 1 is a schematic structural diagram of a microfluidic chip provided by an embodiment of the present invention;
图2为本发明实施例提供的毛细泵结构的结构示意图;Figure 2 is a schematic structural diagram of a capillary pump structure provided by an embodiment of the present invention;
图3为本发明实施例提供的微流控芯片的侧视图。Fig. 3 is a side view of a microfluidic chip provided by an embodiment of the present invention.
图4为本发明实施例提供的微流控芯片的工艺原理图。Fig. 4 is a process principle diagram of a microfluidic chip provided by an embodiment of the present invention.
本发明的最佳实施方式The best mode of the present invention
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative work shall fall within the protection scope of the present invention.
实施例一Example one
请参阅图1,为本发明实施例一提供的微流控芯片的结构示意图,包括:第一微柱阵列110以及由所述第一微柱阵列110分隔的全血微通道120和血浆微通道130。Please refer to FIG. 1, which is a schematic structural diagram of a microfluidic chip provided by Embodiment 1 of the present invention, including: a first micropillar array 110 and a whole blood microchannel 120 and a plasma microchannel separated by the first micropillar array 110 130.
具体地,所述第一微柱阵列110呈螺旋分布。可以理解,微柱阵列110可以呈内螺旋或外螺旋分布,朝向可以是由外向内或者由内向外分布。Specifically, the first micropillar array 110 is spirally distributed. It can be understood that the micropillar array 110 may be distributed in an inner spiral or an outer spiral, and the orientation may be distributed from the outside to the inside or from the inside to the outside.
可以理解,所述第一微柱阵列110的分布形状不限于螺旋状,可以为任意不封闭的回转形状。It can be understood that the distribution shape of the first micro-pillar array 110 is not limited to a spiral shape, and may be any unclosed revolving shape.
具体地,所述第一微柱阵列110的微柱呈圆柱状。所述圆柱状的直径为10~1000微米,相邻圆柱间距为0.5~2.5微米。可以理解,所述圆柱状应对应过滤血液中尺寸较小的红细胞内凹处尺径。Specifically, the micropillars of the first micropillar array 110 are cylindrical. The diameter of the cylinder is 10-1000 microns, and the distance between adjacent cylinders is 0.5-2.5 microns. It can be understood that the cylindrical shape should correspond to the diameter of the inner recess of the red blood cell in the filtered blood with a smaller size.
可以理解,微柱并不局限为圆柱状,还可以为方形、菱形等多种形状,大小尺寸和相邻间距在保证特征尺寸的情况下可设计为不同尺寸,使芯片可以处理不同样品中不同尺寸的细胞,例如:直径为6~20微米的白细胞,厚度为0.5~1.5微米的血小板等。It can be understood that the micro-pillars are not limited to cylindrical shapes, but can also have various shapes such as squares and diamonds. The size and adjacent spacing can be designed in different sizes under the condition of ensuring the feature size, so that the chip can handle different samples in different samples. Cells of different sizes, such as white blood cells with a diameter of 6-20 microns, platelets with a thickness of 0.5-1.5 microns, etc.
上述微流控芯片当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离。In the above-mentioned microfluidic chip, when whole blood enters through the whole blood microchannel, the pores between the micropillar arrays filter the blood cells with a larger size, and at the same time provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel , In order to achieve the separation of blood cells and plasma.
请参阅图2,所述全血微通道120和血浆微通道130的底部均设置毛细泵结构140,所述毛细泵结构140可起到收集、量取血液及血浆的作用。Referring to FIG. 2, the bottoms of the whole blood microchannel 120 and the plasma microchannel 130 are both provided with a capillary pump structure 140, and the capillary pump structure 140 can collect and measure blood and plasma.
具体地,所述毛细泵结构140包括第二微柱阵列结构141,且第二微柱阵列结构141呈有序规则排布。Specifically, the capillary pump structure 140 includes a second micropillar array structure 141, and the second micropillar array structure 141 is arranged in an orderly and regular manner.
可以理解,第二微柱阵列结构141的微柱形状、大小、尺寸等在保证特征尺寸的情况下可以设计为多种参数。此外,毛细泵结构141包括但不限于圣诞树状、蛇形通道状等结构。It can be understood that the shape, size, and size of the micro-pillars of the second micro-pillar array structure 141 can be designed with various parameters under the condition of ensuring the characteristic size. In addition, the capillary pump structure 141 includes, but is not limited to, structures such as a Christmas tree shape, a serpentine channel shape, and the like.
请参阅图3,为本发明实施例提供的微流控芯片的侧视图。Please refer to FIG. 3, which is a side view of a microfluidic chip provided by an embodiment of the present invention.
在本实施例中,所述微流控芯片为单层结构,即全血微通道120和血浆微通道130的通道深度等同于第一微柱阵列110的深度。In this embodiment, the microfluidic chip has a single-layer structure, that is, the channel depth of the whole blood microchannel 120 and the plasma microchannel 130 is equal to the depth of the first micropillar array 110.
具体地,所述全血微通道120和血浆微通道130的通道深度为10~2000微米,宽度为10~5000微米。Specifically, the channel depth of the whole blood microchannel 120 and the plasma microchannel 130 is 10 to 2000 microns, and the width is 10 to 5000 microns.
需要说明的是,血液在微通道中的毛细力会随着通道尺寸减小而增大,拥有更高的流速,从而使得微流控芯片会获得更高的全血分离效率;而微流控芯片整体通量则随着通道尺寸减小而减小,因此根据不同场合所需求的不同侧重点,微通道的宽度与深度可设计为不同尺寸,使最终芯片实现不同的应用要求。It should be noted that the capillary force of blood in the microchannel will increase as the channel size decreases, with a higher flow rate, so that the microfluidic chip will achieve higher separation efficiency of whole blood; while the microfluidic control The overall flux of the chip decreases as the channel size decreases. Therefore, the width and depth of the microchannel can be designed with different sizes according to the different focus requirements of different occasions, so that the final chip can achieve different application requirements.
本发明上述实施例提供的微流控芯片利用微小孔隙对血细胞进行过滤的同时,给血液提供足够的毛细力实现无外源动力控制的全血分离;另外,通过连续的孔隙结构可以解决因血细胞堵塞而带来的全血分离停滞的问题,从而提高全血分离的效率。The microfluidic chip provided by the above-mentioned embodiments of the present invention uses tiny pores to filter blood cells, while providing sufficient capillary force to the blood to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of blood cells. The problem of stagnation of whole blood separation caused by blockage, thereby improving the efficiency of whole blood separation.
实施例二Example two
在本实施例中,本发明提供的微流控芯片可以是能够被微纳加工方法制造的材料,如单晶硅、氧化硅、氮化硅等硅基材料,具体也可以为石英等玻璃材料,或可以为聚二甲基硅氧烷(Polydimethylsiloxane,PDMS)、聚甲基丙烯酸甲酯(Polymethyl methacrylate,PMMA)等高分子材料。针对不同的材料以及芯片中通道所需不同尺寸,制备方法包括但不限于激光刻蚀、3D打印、光刻、等离子体刻蚀等微纳加工方法。In this embodiment, the microfluidic chip provided by the present invention may be a material that can be manufactured by a micro-nano processing method, such as silicon-based materials such as monocrystalline silicon, silicon oxide, and silicon nitride, and specifically may also be glass materials such as quartz. , Or can be polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA) and other polymer materials. For different materials and different sizes of channels in the chip, preparation methods include, but are not limited to, laser etching, 3D printing, photolithography, plasma etching and other micro-nano processing methods.
请参阅图4,为本发明实施例提供的微流控芯片的工艺原理图,具体步骤如下:Please refer to FIG. 4, which is a process schematic diagram of a microfluidic chip provided by an embodiment of the present invention. The specific steps are as follows:
S1:在衬底上悬涂一层光刻胶,利用相应的微通道掩膜版经光刻工艺形成微通道刻蚀窗口,并利用刻蚀工艺去除该部分的阳膜牺牲层。S1: A layer of photoresist is suspended on the substrate, a corresponding microchannel mask is used to form a microchannel etching window through a photolithography process, and the anode film sacrificial layer is removed by an etching process.
在本实施例中,衬底为玻璃或硅。可以理解,衬底包括但不限于石英等玻璃材料和氧化硅、氮化硅等硅基材料。In this embodiment, the substrate is glass or silicon. It can be understood that the substrate includes, but is not limited to, glass materials such as quartz and silicon-based materials such as silicon oxide and silicon nitride.
在本实施例中,阳膜牺牲层包括但不限于光刻胶(包括正性光刻胶、负性光刻胶以及其他光刻胶)、氧化硅、氮化硅、碳化硅、或铬、铝等金属材料。In this embodiment, the positive film sacrificial layer includes but is not limited to photoresist (including positive photoresist, negative photoresist and other photoresists), silicon oxide, silicon nitride, silicon carbide, or chromium, Metal materials such as aluminum.
可以理解,上述微流控芯片制备工艺不局限于实施例中的光刻胶等离子体刻蚀方法,还可以通过激光刻蚀的方式在玻璃或PMMA材料上刻蚀出微流道,通过光刻的方法在玻璃或硅基上制备微柱阵列,再将两者键合;或利用激光直写方式在玻璃或有机材料表面形成流体通道等图案。It can be understood that the above-mentioned microfluidic chip preparation process is not limited to the photoresist plasma etching method in the embodiment, and the microfluidic channel can be etched on glass or PMMA material by laser etching, and the microfluidic channel can be etched by photolithography. The method is to prepare a micropillar array on a glass or silicon substrate, and then bond the two; or use a laser direct writing method to form patterns such as fluid channels on the surface of glass or organic materials.
S2:以衬底上的阳膜层为掩膜,刻蚀微通道所在部分的基底材料,形成了最终的微通道,并去除剩余的阳膜层。S2: Using the cation film layer on the substrate as a mask, etch the base material of the part where the microchannel is located to form the final microchannel, and remove the remaining cation film layer.
在该实施例中,刻蚀包括但不限于等离子体刻蚀、深硅刻蚀以及湿法刻蚀等方式,所述去除工艺包括但不限于浓硫酸以及双氧水的清洗和其他有机溶剂的清洗等工艺。In this embodiment, etching includes but is not limited to plasma etching, deep silicon etching, and wet etching. The removal process includes, but is not limited to, cleaning with concentrated sulfuric acid and hydrogen peroxide, and cleaning with other organic solvents. Craft.
S3:对带有微通道结构的微流控芯片进行表面化学处理,实现微流控芯片表面的亲水化处理,并提高芯片表面物化性质的稳定性和均一性。S3: Perform surface chemical treatment on the microfluidic chip with a microchannel structure to realize the hydrophilic treatment of the surface of the microfluidic chip and improve the stability and uniformity of the physical and chemical properties of the chip surface.
对带有微通道结构的微流控芯片进行表面化学处理方法不局限于浸泡、熏蒸、喷涂等化学方法,还可以采用电化学、热加工、气相沉积等方法。The surface chemical treatment method for the microfluidic chip with the microchannel structure is not limited to chemical methods such as immersion, fumigation, spraying, etc., and electrochemical, thermal processing, vapor deposition and other methods can also be used.
在该实施例中,所用化学处理试剂包括但不限于聚乙二醇(Polyethylene glycol,PEG)和3-氨丙基三乙氧基硅烷((3-aminopropyl)triethoxysilane,APTES)等,所用处理方式包括但不限于熏蒸、浸泡、喷涂等。In this embodiment, the chemical treatment reagents used include, but are not limited to, polyethylene glycol (PEG) and 3-aminopropyl triethoxysilane ((3-aminopropyl) triethoxysilane, APTES), etc. The treatment method used Including but not limited to fumigation, soaking, spraying, etc.
可以理解,通过表面化学处理可实现微流控芯片以下功能:(1)亲水化,有利于提高全血样品在表面的毛细力驱动能力;(2)提高芯片表面物化性质的均一性和稳定性,以阻隔基底对血液中细胞、蛋白的非特异性吸附,使全血样品通过时不容易发生粘附、停滞。It can be understood that the following functions of the microfluidic chip can be achieved through surface chemical treatment: (1) Hydrophilization, which is beneficial to improve the capillary force driving ability of the whole blood sample on the surface; (2) Improve the uniformity and stability of the physical and chemical properties of the chip surface It can prevent the substrate from non-specific adsorption of cells and proteins in the blood, so that the whole blood sample is not prone to adhesion and stagnation when passing through.
通过上述步骤制备得到的微流控芯片包括第一微柱阵列以及由所述第一微柱阵列分隔的全血微通道和血浆微通道,当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离。The microfluidic chip prepared by the above steps includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array. When whole blood enters through the whole blood microchannel, the The pores between the microcolumn arrays filter the blood cells of larger size, and provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
本发明上述实施例提供的微流控芯片利用微小孔隙对血细胞进行过滤的同时,给血液提供足够的毛细力实现无外源动力控制的全血分离;另外,通过连续的孔隙结构可以解决因血细胞堵塞而带来的全血分离停滞的问题,从而提高全血分离的效率The microfluidic chip provided by the above-mentioned embodiments of the present invention uses tiny pores to filter blood cells, while providing sufficient capillary force to the blood to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of blood cells. The problem of stagnant whole blood separation caused by blockage, thereby improving the efficiency of whole blood separation
实施例三Example three
本发明还提供了一种基于所述的微流控芯片的全血分离方法,包括下述步骤:The present invention also provides a whole blood separation method based on the microfluidic chip, which includes the following steps:
步骤S110:待分离血液运动扩散至最近的所述第一微柱的微柱处,并在所述微柱间隙处停滞,待分离血液在毛细力作用下沿所述全血微通道自驱动,同时过程中依次经过后续微柱间隙并停滞,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来;分离的血浆将经起始点通过微柱间隙并沿所述血浆微通道向前自驱动,并逐个触发流经的微柱间隙,持续不断地从全血中过滤出血浆。Step S110: the movement of the blood to be separated spreads to the nearest micro-pillar of the first micro-pillar, and stops at the gap between the micro-pillars, and the blood to be separated is self-driving along the whole blood microchannel under the action of capillary force, At the same time, the process passes through the subsequent micro-column gaps and stagnates. The pores between the micro-column arrays filter larger blood cells and provide capillary force to separate the plasma; the separated plasma will pass through the micro-column gap through the starting point and travel along the path. The plasma microchannel is self-driving forward and triggers the microcolumn gaps flowing through one by one to continuously filter the plasma from the whole blood.
具体地,在所述微流控芯片的进样口加入待分离的血液样本(图三中A处为进样口),待分离血液有进样口运动扩散至最近的所述第一微柱的微柱处。Specifically, the blood sample to be separated is added to the injection port of the microfluidic chip (A in Figure 3 is the injection port), and the blood to be separated has the injection port movement and spreads to the nearest first microcolumn的微柱处。 At the micro-column.
可以理解,所述微流控芯片入口不局限于一个进样口,可以设计为多个入口,每一个入口可以接入单个或多个第一微柱阵列,每一个第一微柱阵列也可以接入单个或多个入口。It can be understood that the inlet of the microfluidic chip is not limited to one sample inlet, and can be designed as multiple inlets. Each inlet can be connected to a single or multiple first micropillar arrays, and each first micropillar array can also be Access single or multiple entrances.
步骤S110:血液及血浆在所述全血微通道和所述血浆微通道的底端分别进入所述毛细泵结构,所述毛细泵结构收集、量取血液和血浆。Step S110: blood and plasma enter the capillary pump structure at the bottom ends of the whole blood microchannel and the plasma microchannel respectively, and the capillary pump structure collects and measures blood and plasma.
本发明提供的微流控芯片,包括第一微柱阵列以及由所述第一微柱阵列分隔的全血微通道和血浆微通道,当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离,本发明提供的微流控芯片利用微小孔隙对血细胞进行过滤的同时,给血液提供足够的毛细力实现无外源动力控制的全血分离;另外,通过连续的孔隙结构可以解决因血细胞堵塞而带来的全血分离停滞的问题,从而提高全血分离的效率。The microfluidic chip provided by the present invention includes a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array. When whole blood enters through the whole blood microchannel, the microchannel The pores between the column arrays filter larger blood cells and provide capillary force to separate the plasma. The separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma. The microfluidic chip provided by the present invention utilizes tiny pores. While filtering blood cells, it provides sufficient capillary force to achieve whole blood separation without external power control; in addition, the continuous pore structure can solve the problem of stagnant separation of whole blood caused by clogging of blood cells, thereby improving The efficiency of whole blood separation.
此外,本发明提供的微流控芯片,采取毛细力自驱动的方式实现全血分离,无需外源动力控制装置,在集成化、微小型化的发展上更具潜力。In addition, the microfluidic chip provided by the present invention adopts a capillary force self-driving manner to realize whole blood separation, does not require an external power control device, and has more potential for the development of integration and miniaturization.
本发明提供的微流控芯片,不局限于全血/血浆分离,也可以用于分离、富集溶液体系中不同层次的生物对象如细胞层面的循环肿瘤细胞,如亚细胞层面的细胞外囊泡、脂质体等。The microfluidic chip provided by the present invention is not limited to whole blood/plasma separation, but can also be used to separate and enrich different levels of biological objects in a solution system, such as circulating tumor cells at the cell level, such as extracellular vesicles at the subcellular level. Bubbles, liposomes, etc.
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。The technical features of the above-mentioned embodiments can be combined arbitrarily. In order to make the description concise, all possible combinations of the various technical features in the above-mentioned embodiments are not described. However, as long as there is no contradiction in the combination of these technical features, All should be considered as the scope of this specification.
当然本发明的微流控芯片正极材料还可具有多种变换及改型,并不局限于上述实施方式的具体结构。总之,本发明的保护范围应包括那些对于本领域普通技术人员来说显而易见的变换或替代以及改型。Of course, the positive electrode material of the microfluidic chip of the present invention can also have various transformations and modifications, and is not limited to the specific structure of the above-mentioned embodiment. In short, the protection scope of the present invention should include those alterations or substitutions and modifications that are obvious to those of ordinary skill in the art.

Claims (9)

  1. 一种微流控芯片,其特征在于,包括第一微柱阵列以及由所述第一微柱阵列分隔的全血微通道和血浆微通道,当全血由所述全血微通道进入,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来,分离的血浆进入所述血浆微通道,以实现血细胞和血浆的分离。A microfluidic chip, which is characterized by comprising a first micropillar array and a whole blood microchannel and a plasma microchannel separated by the first micropillar array. When whole blood enters from the whole blood microchannel, The pores between the microcolumn arrays filter blood cells with a larger size and provide capillary force to separate the plasma, and the separated plasma enters the plasma microchannel to realize the separation of blood cells and plasma.
  2. 如权利要求1所述的微流控芯片,其特征在于,所述第一微柱阵列呈螺旋分布。8. The microfluidic chip of claim 1, wherein the first micropillar array is spirally distributed.
  3. 如权利要求1所述的微流控芯片,其特征在于,所述第一微柱阵列的微柱呈圆柱状。The microfluidic chip of claim 1, wherein the micropillars of the first micropillar array are cylindrical.
  4. 如权利要求3所述的微流控芯片,其特征在于,所述圆柱状的直径为10~1000微米,相邻圆柱间距为0.5~2.5微米。The microfluidic chip of claim 3, wherein the diameter of the cylindrical shape is 10 to 1000 microns, and the distance between adjacent cylinders is 0.5 to 2.5 microns.
  5. 如权利要求1所述的微流控芯片,其特征在于,所述全血微通道和血浆微通道的底部均设置毛细泵结构。The microfluidic chip of claim 1, wherein the bottoms of the whole blood microchannel and the plasma microchannel are both provided with a capillary pump structure.
  6. 如权利要求5所述的微流控芯片,其特征在于,所述毛细泵结构包括第二微柱阵列结构。8. The microfluidic chip of claim 5, wherein the capillary pump structure comprises a second micropillar array structure.
  7. 如权利要求6所述的微流控芯片,其特征在于,所述第二微柱阵列结构呈规则排布。7. The microfluidic chip of claim 6, wherein the second micropillar array structure is arranged regularly.
  8. 如权利要求1所述的微流控芯片,其特征在于,所述微流控芯片为单层或者多层结构,所述全血微通道和血浆微通道的微通道深度为10~2000微米,宽度为10~5000微米。The microfluidic chip of claim 1, wherein the microfluidic chip has a single-layer or multi-layer structure, and the microchannel depth of the whole blood microchannel and the plasma microchannel is 10 to 2000 microns, The width is 10~5000 microns.
  9. 一种基于权利要求1至8任一项所述的微流控芯片的全血分离方法,其特征在于,包括下述步骤:A whole blood separation method based on the microfluidic chip according to any one of claims 1 to 8, characterized in that it comprises the following steps:
    待分离血液运动扩散至最近的所述第一微柱的微柱处,并在所述微柱间隙处停滞,待分离血液在毛细力作用下沿所述全血微通道自驱动,同时过程中依次经过后续微柱间隙并停滞,所述微柱阵列间的孔隙过滤尺寸较大的血细胞,同时提供毛细力将血浆分离出来;分离的血浆将经起始点通过微柱间隙并沿所述血浆微通道向前自驱动,并逐个触发流经的微柱间隙,持续不断地从全血中过滤出血浆; The movement of the blood to be separated spreads to the nearest micro-column of the first micro-column and stagnates at the gap between the micro-columns. The blood to be separated is driven by the capillary force along the whole blood micro-channel, and at the same time in the process After passing through the micro-column gap in turn and stagnating, the pores between the micro-column arrays filter larger blood cells while providing capillary force to separate the plasma; the separated plasma will pass through the micro-column gap through the starting point and travel along the plasma micro-columns. The channel is self-driving forward and triggers the micro-column gap flowing through one by one, continuously filtering out plasma from the whole blood;
    血液及血浆在所述全血微通道和所述血浆微通道的底端分别进入所述毛细泵结构,所述毛细泵结构收集、量取血液和血浆。Blood and plasma enter the capillary pump structure at the bottom ends of the whole blood microchannel and the plasma microchannel respectively, and the capillary pump structure collects and measures blood and plasma.
PCT/CN2020/129487 2019-12-13 2020-11-17 Microfluidic chip and whole blood separation method based on microfluidic chip WO2021115047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911289476.0A CN111001451A (en) 2019-12-13 2019-12-13 Microfluidic chip and whole blood separation method based on microfluidic chip
CN201911289476.0 2019-12-13

Publications (1)

Publication Number Publication Date
WO2021115047A1 true WO2021115047A1 (en) 2021-06-17

Family

ID=70115259

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2020/129487 WO2021115047A1 (en) 2019-12-13 2020-11-17 Microfluidic chip and whole blood separation method based on microfluidic chip

Country Status (2)

Country Link
CN (1) CN111001451A (en)
WO (1) WO2021115047A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111001451A (en) * 2019-12-13 2020-04-14 深圳先进技术研究院 Microfluidic chip and whole blood separation method based on microfluidic chip
CN112481080B (en) * 2020-12-10 2023-03-24 深圳先进技术研究院 Micro-fluidic chip, micro-fluidic chip preparation method and nucleic acid extraction method

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101086504A (en) * 2006-06-06 2007-12-12 北京大学 Microfluid centrifugal chip and its processing method
JP2010256304A (en) * 2009-04-28 2010-11-11 Shibaura Institute Of Technology Circulation type corpuscle separation filter chip
CN101962614A (en) * 2010-08-11 2011-02-02 清华大学 Biochip and preparation method thereof
CN102162815A (en) * 2011-01-07 2011-08-24 北京大学 Plasma separating chip and preparation method thereof
CN102175840A (en) * 2010-12-30 2011-09-07 北京大学 Whole blood centrifugal separation chip and preparation method thereof
CN102896006A (en) * 2012-10-09 2013-01-30 中国科学院半导体研究所 Microsphere separation and screening chip and preparation method thereof
CN105462834A (en) * 2016-01-22 2016-04-06 苏州汶颢芯片科技有限公司 Tumor cell capturing micro-fluidic chip and tumor cell capturing method
CN106434302A (en) * 2016-09-18 2017-02-22 华中科技大学 Portable non-power-source microfluidic cell separation chip
CN107702973A (en) * 2017-09-08 2018-02-16 深圳市太赫兹科技创新研究院有限公司 A kind of whole blood blood plasma piece-rate system and method
WO2019117800A1 (en) * 2017-12-11 2019-06-20 A. Menarini Biomarkers Singapore Pte Ltd Microfluidic device and method for cell separation of a blood sample
CN111001451A (en) * 2019-12-13 2020-04-14 深圳先进技术研究院 Microfluidic chip and whole blood separation method based on microfluidic chip

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100564541C (en) * 2005-06-13 2009-12-02 中国科学院电子学研究所 Preprocessed chip of porous silica microfluid sample
CN100503422C (en) * 2005-07-07 2009-06-24 中国科学院电子学研究所 Microstructure cross-flow type separate chip
CN101498630B (en) * 2008-01-30 2012-06-27 中国科学院电子学研究所 Sample pretreatment integrated chip
CN101650370B (en) * 2008-08-13 2013-05-01 中国科学院电子学研究所 Integrated microfluidic sensing chip and method for detecting microfluid
WO2012016136A2 (en) * 2010-07-30 2012-02-02 The General Hospital Corporation Microscale and nanoscale structures for manipulating particles
CN103285949A (en) * 2013-05-27 2013-09-11 苏州扬清芯片科技有限公司 Micro-fluidic serum extracting chip
CN104668002B (en) * 2014-05-22 2016-03-16 Imec非营利协会 Compact fluid analysis device and manufacture method thereof
CN109939751B (en) * 2017-12-21 2023-06-27 东莞东阳光科研发有限公司 Microfluidic chip, detection device and detection method for whole blood detection
CN109453827A (en) * 2018-12-19 2019-03-12 清华大学天津高端装备研究院 The micro-fluidic chip of flow control is realized based on the microarray of lyophily and/or lyophoby

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101086504A (en) * 2006-06-06 2007-12-12 北京大学 Microfluid centrifugal chip and its processing method
JP2010256304A (en) * 2009-04-28 2010-11-11 Shibaura Institute Of Technology Circulation type corpuscle separation filter chip
CN101962614A (en) * 2010-08-11 2011-02-02 清华大学 Biochip and preparation method thereof
CN102175840A (en) * 2010-12-30 2011-09-07 北京大学 Whole blood centrifugal separation chip and preparation method thereof
CN102162815A (en) * 2011-01-07 2011-08-24 北京大学 Plasma separating chip and preparation method thereof
CN102896006A (en) * 2012-10-09 2013-01-30 中国科学院半导体研究所 Microsphere separation and screening chip and preparation method thereof
CN105462834A (en) * 2016-01-22 2016-04-06 苏州汶颢芯片科技有限公司 Tumor cell capturing micro-fluidic chip and tumor cell capturing method
CN106434302A (en) * 2016-09-18 2017-02-22 华中科技大学 Portable non-power-source microfluidic cell separation chip
CN107702973A (en) * 2017-09-08 2018-02-16 深圳市太赫兹科技创新研究院有限公司 A kind of whole blood blood plasma piece-rate system and method
WO2019117800A1 (en) * 2017-12-11 2019-06-20 A. Menarini Biomarkers Singapore Pte Ltd Microfluidic device and method for cell separation of a blood sample
CN111001451A (en) * 2019-12-13 2020-04-14 深圳先进技术研究院 Microfluidic chip and whole blood separation method based on microfluidic chip

Also Published As

Publication number Publication date
CN111001451A (en) 2020-04-14

Similar Documents

Publication Publication Date Title
US10596522B2 (en) Hemolysis-free blood plasma separation
US7743928B2 (en) Integrated apparatus and methods for treating liquids
US20110081674A1 (en) Continuous-flow deformability-based cell separation
Wu et al. Blood cell-free plasma separated from blood samples with a cascading weir-type microfilter using dead-end filtration
US20150299729A1 (en) Ultrahigh throughput microinjection device
CN102513169B (en) Microfluidic device used in micron-grade particle high-flux separation, and manufacturing method thereof
CN103894248A (en) Micro-fluidic chip and micro-fluidic chip system for single cell analysis and single cell analyzing method
ES2784933T3 (en) Microfluidic device
WO2021115047A1 (en) Microfluidic chip and whole blood separation method based on microfluidic chip
WO2017116214A1 (en) Device for separating or aligning fine particles, and method for separating or aligning fine particles using same
Sahore et al. Droplet microfluidics in thermoplastics: device fabrication, droplet generation, and content manipulation using integrated electric and magnetic fields
CN110918144A (en) Microfluidic chip and whole blood separation method based on microfluidic chip
US8354075B1 (en) Streamline-based microfluidic device
CN208642693U (en) Chip and water quality many reference amounts detection device
Kuo et al. Microfluidic chip for rapid and automatic extraction of plasma from whole human blood
JP2006095515A (en) Membrane device and using method for the same
CN111330660A (en) Centrifugal high-flux micro-droplet preparation chip
JP2004033919A (en) Micro fluid control mechanism and microchip
Meng-Di et al. Microchannel with stacked microbeads for separation of plasma from whole blood
CN113042121A (en) Integrated chip for exosome nucleic acid detection, detection method and application
JP2005031070A (en) Micro fluid control mechanism and microchip
JP7289128B2 (en) Manufacturing method of cross-flow filtration device
CN109985681B (en) Micro-droplet generating device
CN113820487A (en) Micro-fluidic chip for cancer marker detection and preparation method thereof
KR20150014781A (en) Apparatus for filtering a fluid and method of isolating a particle using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20899081

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20899081

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 12.01.2023)

122 Ep: pct application non-entry in european phase

Ref document number: 20899081

Country of ref document: EP

Kind code of ref document: A1